Director at Alamar Biosciences (NASDAQ: ALMR) updates stock option grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Alamar Biosciences director Rebecca Chambers reported an internal restructuring of stock options, not an open-market trade. One option covering 140,612 shares of Common Stock at an exercise price of $7.60 per share is now recorded as outstanding, while a corresponding option tied to 140,612 shares of Class B Common Stock was removed.
Each share of Class B Common Stock was reclassified into one share of Common Stock immediately before the company’s initial public offering, and the option reflects that change. Twenty-five percent of the option vests on January 15, 2027, with the remaining shares vesting in equal monthly installments over the following three years, and the option expires on January 14, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Chambers Rebecca
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Stock Option (Right to Buy) | 140,612 | $0.00 | -- |
| Other | Stock Option (Right to Buy) | 140,612 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 shares (Direct, null)
Footnotes (1)
- Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. Twenty-five percent of the shares subject to the option vest on January 15, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date.
Key Figures
Option size: 140,612 shares
Underlying Class B option removed: 140,612 shares
Exercise price: $7.60 per share
+3 more
6 metrics
Option size
140,612 shares
Stock option over Common Stock reported for Rebecca Chambers
Underlying Class B option removed
140,612 shares
Class B Common Stock option position reduced to zero
Exercise price
$7.60 per share
Exercise price for the reported stock option
Expiration date
January 14, 2036
Option term end for Chambers’ stock option
Initial vesting date
January 15, 2027
25% of option shares vest on this date
Restructured shares total
281,224 shares
Shares involved in restructuring transactions coded J
Key Terms
Stock Option (Right to Buy), Class B Common Stock, initial public offering, vest, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy) with 140,612 shares"
Class B Common Stock financial
"underlying_security_title: Class B Common Stock with 140,612 shares"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
initial public offering financial
"reclassified into one share of Common Stock immediately prior to the completion of the initial public offering"
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.
vest financial
"Twenty-five percent of the shares subject to the option vest on January 15, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
transaction code J financial
"transaction_code: J, described as Other acquisition or disposition"
FAQ
What insider transaction did Alamar Biosciences (ALMR) report for Rebecca Chambers?
Alamar Biosciences reported that director Rebecca Chambers restructured stock options covering 140,612 shares. The filing shows an option over Common Stock recorded as outstanding and a corresponding Class B Common Stock option removed, with no market purchase or sale of shares disclosed.
What is the exercise price and expiration date of the Alamar Biosciences (ALMR) option?
The stock option reported for Rebecca Chambers has an exercise price of $7.60 per share and expires on January 14, 2036. These terms define the price she would pay to acquire shares and how long the option remains available before it lapses.
How does the Alamar Biosciences (ALMR) option for Rebecca Chambers vest?
The option vests 25% of its shares on January 15, 2027, with the remaining shares vesting in equal monthly installments over the following 36 months. Vesting depends on Rebecca Chambers’ continuous service with the company through each scheduled vesting date.
Why does the Alamar Biosciences (ALMR) filing mention Class B Common Stock?
The filing explains that each share of Class B Common Stock was reclassified into one share of Common Stock immediately before the company’s initial public offering. The option records this reclassification by shifting from a Class B Common Stock underlying security to Common Stock.